122 related articles for article (PubMed ID: 9051071)
1. Profound hearing loss from intravertebral artery cisplatin.
Wetmore SJ; Koike KJ; Bloomfield SM
Otolaryngol Head Neck Surg; 1997 Feb; 116(2):234-7. PubMed ID: 9051071
[No Abstract] [Full Text] [Related]
2. [Evaluation of hearing in children with solid tumors treated by chemotherapy].
Gryczyńska D; Rychwalska M; Pekacka K; Krawczyński M; Bodalski J
Otolaryngol Pol; 2001; 55(2):179-83. PubMed ID: 11494735
[TBL] [Abstract][Full Text] [Related]
3. Audiometric patterns in ototoxicity of intra-arterial Cisplatin chemoradiation in patients with locally advanced head and neck cancer.
Zuur CL; Simis YJ; Lansdaal PE; Rasch CR; Tange RA; Balm AJ; Dreschler WA
Audiol Neurootol; 2006; 11(5):318-30. PubMed ID: 16983183
[TBL] [Abstract][Full Text] [Related]
4. Intracarotid cisplatin chemotherapy for high-grade astrocytomas.
Brambilla Bas M; Boccardo M
J Neurosurg Sci; 1993 Jun; 37(2):83-6. PubMed ID: 8301375
[TBL] [Abstract][Full Text] [Related]
5. Distortion product otoacoustic emissions test is useful in children undergoing cisplatin treatment.
Toral-Martiñón R; Shkurovich-Bialik P; Collado-Corona MA; Mora-Magaña I; Goldgrub-Listopad S; Shkurovich-Zaslavsky M
Arch Med Res; 2003; 34(3):205-8. PubMed ID: 14567400
[TBL] [Abstract][Full Text] [Related]
6. The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy.
Abujamra AL; Escosteguy JR; Dall'Igna C; Manica D; Cigana LF; Coradini P; Brunetto A; Gregianin LJ
Pediatr Blood Cancer; 2013 Mar; 60(3):474-8. PubMed ID: 22744939
[TBL] [Abstract][Full Text] [Related]
7. [Hearing loss caused by high dose carboplatin therapy].
Lautermann J; Adamczyk M; ten Cate WJ; Kloke O
Laryngorhinootologie; 1998 Feb; 77(2):82-4. PubMed ID: 9555700
[TBL] [Abstract][Full Text] [Related]
8. Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis.
Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Rasch CR; Schornagel JH; Dreschler WA; Balm AJ
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1320-5. PubMed ID: 17418969
[TBL] [Abstract][Full Text] [Related]
9. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Schornagel JH; Dreschler WA; Rasch CR; Balm AJ
J Clin Oncol; 2007 Aug; 25(24):3759-65. PubMed ID: 17704425
[TBL] [Abstract][Full Text] [Related]
10. Intra-arterial cisplatin in malignant brain tumors: incidence and severity of otic toxicity.
Assietti R; Olson JJ
J Neurooncol; 1996 Mar; 27(3):251-8. PubMed ID: 8847559
[TBL] [Abstract][Full Text] [Related]
11. [Ototoxicity of cisplatin chemotherapy in patients with ovarian cancer].
Beck E; Schuster M; Berg A; Jäger W; Wildt L; Lang N
Gynakol Rundsch; 1991; 31 Suppl 2():280-5. PubMed ID: 1790954
[No Abstract] [Full Text] [Related]
12. Cisplatin: continuous versus bolus.
Gratton MA; Smyth BJ
J Pediatr Hematol Oncol; 2006 Feb; 28(2):60-1. PubMed ID: 16462573
[No Abstract] [Full Text] [Related]
13. Erythropoietin and astrocytomas.
Rutka JT
J Neurosurg; 2007 Feb; 106(2):337; discussion 337. PubMed ID: 17410720
[No Abstract] [Full Text] [Related]
14. Ototoxic effects of supradose cisplatin with sodium thiosulfate neutralization in patients with head and neck cancer.
Madasu R; Ruckenstein MJ; Leake F; Steere E; Robbins KT
Arch Otolaryngol Head Neck Surg; 1997 Sep; 123(9):978-81. PubMed ID: 9305250
[TBL] [Abstract][Full Text] [Related]
15. Time course and clinical characterization of cisplatin-induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population.
Chan SL; Ng LS; Goh X; Siow CH; Goh HL; Goh BC; Cheo T; Loh KS; Brunham LR
Head Neck; 2018 Jul; 40(7):1425-1433. PubMed ID: 29451951
[TBL] [Abstract][Full Text] [Related]
16. Comparison of radiation and chemoradiation-induced sensorineural hearing loss in head and neck cancer patients.
Mahdavi SR; Rezaeyan A; Nikoofar A; Bakhshandeh M; Farahani S; Cheraghi S
J Cancer Res Ther; 2020; 16(3):539-545. PubMed ID: 32719264
[TBL] [Abstract][Full Text] [Related]
17. Cisplatinum ototoxicity in children, long-term follow up.
Al-Khatib T; Cohen N; Carret AS; Daniel S
Int J Pediatr Otorhinolaryngol; 2010 Aug; 74(8):913-9. PubMed ID: 20846503
[TBL] [Abstract][Full Text] [Related]
18. [Monitoring hearing during ototoxic cisplatin therapy].
Kluba J; Kluba U; von Specht H; Mittler U
Padiatr Grenzgeb; 1990; 29(1):19-23. PubMed ID: 2342815
[TBL] [Abstract][Full Text] [Related]
19. Recovery from cisplatin-induced ototoxicity: a case report and review.
Truong MT; Winzelberg J; Chang KW
Int J Pediatr Otorhinolaryngol; 2007 Oct; 71(10):1631-8. PubMed ID: 17706797
[TBL] [Abstract][Full Text] [Related]
20. Transient-evoked otoacoustic emissions in children after cisplatin chemotherapy.
Allen GC; Tiu C; Koike K; Ritchey AK; Kurs-Lasky M; Wax MK
Otolaryngol Head Neck Surg; 1998 May; 118(5):584-8. PubMed ID: 9591854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
